Skyhawk Secures $2 Billion Boost from Merck KGaA for RNA Mission
Skyhawk Therapeutics has secured a significant financial boost, with Merck KGaA committing $2 billion to support its RNA mission. This partnership marks a pivotal moment for Skyhawk, as it becomes…